Product Program year 2025 Source: CMS Open Payments

Illumisite

Device Interventional Lung Solutions

PDI 10884521723818

Open in the dashboard

General payments

$1,057,998

4,819 payments

Research payments

$0

0 payments

Through program year 2025, $1,057,998 in general payments and $0 in research payments were reported against Illumisite (Interventional Lung Solutions).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $84,679 802
2024 General $288,386 1,506
2023 General $331,090 1,160
2022 General $291,139 1,109
2021 General $62,703 242

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $1,057,998 4,819 payments
Top recipients General payments · program year 2025
  1. Jonathan Kurman Pulmonary Disease · Milwaukee, WI $6,080 7% · 5 payments
  2. Jon Freels Pulmonary Disease · Columbia, TN $6,032 7% · 9 payments
  3. Todd Hoopman Pulmonary Disease · Coeur D Alene, ID $5,514 7% · 12 payments
  4. Adam Kole Radiation Oncology · Birmingham, AL $2,614 3% · 4 payments
  5. Michael Bann Hospitalist · Columbus, OH $1,923 2% · 13 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $59,094 71% · 135 practitioners
  2. Internal Medicine $7,165 9% · 21 practitioners
  3. Critical Care Medicine Internal Medicine $7,059 8% · 27 practitioners
  4. Radiation Oncology Radiology $3,156 4% · 13 practitioners
  5. Hospitalist $1,923 2% · 1 practitioner

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Tennessee $10,942 13% · 10 recipients
  2. North Carolina $8,378 10% · 25 recipients
  3. Illinois $6,419 8% · 13 recipients
  4. Wisconsin $6,246 7% · 2 recipients
  5. Texas $5,703 7% · 31 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,819 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record